Key facts
- It has raised $83.1M; the latest was Later Stage VC ($13.6M) in May 2024.
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for InnoMedica
- ·The full record, as it builds
Funding rounds
No funding rounds for InnoMedica are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About InnoMedica
Operator of a pharmaceutical company intended to provide patients with effective improvements in therapy. The company offers nanotechnology for the targeted treatment of diseases, nanocarriers, and pharmaceutical agents that circulate in the bloodstream for longer and are released at the designated location in the body with precision, enabling researchers to develop novel therapeutics for treating tumor diseases.
- Sector
- Healthcare
- HQ
- Zug, Switzerland
- Founded
- 2000
- Employees
- 56
- Website
- innomedica.com/
- Ownership
- Privately Held (backing)
InnoMedica doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in InnoMedica shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on InnoMedica in its N-PORT filings yet. We sweep new filings monthly.